OpenLoop has acquired AI communication platform Hey Revia, folding the company's automated patient engagement tools into its virtual care infrastructure. The deal, announced amid a week of accelerating digital health M&A, signals that telehealth companies are moving to buy rather than build the AI capabilities they need to scale.
The acquisition gives OpenLoop a system designed to handle ongoing patient communication at scale - a growing challenge as telehealth volumes rise. Hey Revia had focused on automating how clinical teams interact with patients. Financial terms were not disclosed.
FDA breakthrough status for hemorrhage detection
The FDA granted breakthrough device designation to Aurenar for a device targeting brain bleeds. The designation is reserved for technologies that could improve treatment or diagnosis of life-threatening conditions, and it starts a faster, more collaborative review process.
Intracranial hemorrhage requires rapid detection. The FDA's move puts Aurenar on an expedited path toward potential clearance, acknowledging that the device may advance what clinicians currently have available in emergency settings.
Sharecare leans on AWS for multi-model AI navigation
Sharecare announced it is using Amazon Web Services to power AskMD, its AI health navigation tool. The platform runs on Amazon Bedrock, which lets Sharecare orchestrate several foundation models at once. Users can work through symptoms, check insurance benefits, find providers, and assess care options through a single interface.
Coordinating multiple models rather than relying on a single one gives Sharecare flexibility to route queries to the model best suited for each task. The deployment also places Sharecare among a growing cluster of health technology firms building on major cloud AI infrastructure. These deals reflect the pace of AI for Healthcare integration across clinical and operational workflows.
Investors bet on housing as a health intervention
Upside, a platform focused on housing stability for healthcare populations, raised $20 million. The round highlights continued investor interest in companies that address non-clinical factors - like stable housing - that directly affect health outcomes and total cost of care.
Data standards debate at HIMSS AI forum
At the HIMSS AI in Healthcare Forum in Boston, health system leaders discussed practical AI deployment, risk management, and building trust among patients and clinicians. In a separate conversation, Álvaro Alonso Zorita of Spain's National Health System told HIMSS TV that common data standards are essential for scaling AI tools across Spain's healthcare network efficiently.
The emphasis on data standardization echoes concerns from health IT leaders in other markets, who identify fragmented data infrastructure as the primary bottleneck slowing AI adoption - even when the models themselves are ready to deploy.
Why this matters for healthcare
For clinical and operational leaders, the week's announcements clarify three signals. First, the buyer's market for AI-driven patient engagement software is heating up, which may accelerate the availability of turnkey communication tools. Second, Aurenar's breakthrough designation puts pressure on emergency departments to evaluate how AI-assisted hemorrhage detection could fit into triage workflows. Third, the Sharecare-AWS model shows that multi-model orchestration on cloud infrastructure is moving from pilot to production - and it will require IT teams to revisit their data integration roadmaps sooner rather than later.
Your membership also unlocks:
